Extrait

To explore the cross neutralizing potential of human sera after primary immunization with FSME-IMMUN 0.5 ml and Encepur 0.5 ml against different strains within the same TBEV subtype, other TBEV subtypes, closely related viruses of the TBEV serogroup, and also more distantly related flaviviruses, based on the use of a hybrid virus assay platform.

Critère d'inclusion

• The study is exploring the cross neutralizing potential of human sera after primary immunization with FSME-IMMUN 0.5 ml or Encepur 0.5 ml against different strains within the same TBEV subtype, other TBEV subtypes, closely related viruses of the TBEV serogroup, and also more distantly related flaviviruses, based on the use of a hybrid virus assay platform

Liens

• euctr